Zymeworks Common Stock Stock Price Patterns
| ZYME Stock | USD 22.53 0.15 0.67% |
Momentum 43
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.24) | EPS Estimate Current Year (0.87) | EPS Estimate Next Year 0.3266 | Wall Street Target Price 35.6154 | EPS Estimate Current Quarter (0.32) |
Using Zymeworks Common hype-based prediction, you can estimate the value of Zymeworks Common Stock from the perspective of Zymeworks Common response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Zymeworks Common using Zymeworks Common's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Zymeworks using crowd psychology based on the activity and movement of Zymeworks Common's stock price.
Zymeworks Common Short Interest
A significant increase or decrease in Zymeworks Common's short interest from the previous month could be a good indicator of investor sentiment towards Zymeworks. Short interest can provide insight into the potential direction of Zymeworks Common stock and how bullish or bearish investors feel about the market overall.
200 Day MA 17.0268 | Short Percent 0.0749 | Short Ratio 4.28 | Shares Short Prior Month 3.6 M | 50 Day MA 25.0371 |
Zymeworks Common Stock Hype to Price Pattern
Investor biases related to Zymeworks Common's public news can be used to forecast risks associated with an investment in Zymeworks. The trend in average sentiment can be used to explain how an investor holding Zymeworks can time the market purely based on public headlines and social activities around Zymeworks Common Stock. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Zymeworks Common's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Zymeworks Common.
Zymeworks Common Implied Volatility | 2.14 |
Zymeworks Common's implied volatility exposes the market's sentiment of Zymeworks Common Stock stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Zymeworks Common's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Zymeworks Common stock will not fluctuate a lot when Zymeworks Common's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Zymeworks Common to buy its stock at a price that has no basis in reality. In that case, they are not buying Zymeworks because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Zymeworks Common after-hype prediction price | USD 22.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Zymeworks contract
Based on the Rule 16, the options market is currently suggesting that Zymeworks Common Stock will have an average daily up or down price movement of about 0.13% per day over the life of the 2026-04-17 option contract. With Zymeworks Common trading at USD 22.53, that is roughly USD 0.0301 . If you think that the market is fully incorporating Zymeworks Common's daily price movement you should consider acquiring Zymeworks Common Stock options at the current volatility level of 2.14%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Zymeworks | Build AI portfolio with Zymeworks Stock |
Zymeworks Common After-Hype Price Density Analysis
As far as predicting the price of Zymeworks Common at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Zymeworks Common or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Zymeworks Common, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Zymeworks Common Estimiated After-Hype Price Volatility
In the context of predicting Zymeworks Common's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Zymeworks Common's historical news coverage. Zymeworks Common's after-hype downside and upside margins for the prediction period are 17.08 and 27.06, respectively. We have considered Zymeworks Common's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Zymeworks Common is not too volatile at this time. Analysis and calculation of next after-hype price of Zymeworks Common Stock is based on 3 months time horizon.
Zymeworks Common Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Zymeworks Common is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zymeworks Common backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Zymeworks Common, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.40 | 4.99 | 0.46 | 0.13 | 13 Events / Month | 7 Events / Month | In about 13 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
22.53 | 22.07 | 2.04 |
|
Zymeworks Common Hype Timeline
Zymeworks Common Stock is at this time traded for 22.53. The entity has historical hype elasticity of -0.46, and average elasticity to hype of competition of -0.13. Zymeworks is expected to decline in value after the next headline, with the price expected to drop to 22.07. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.04%, whereas the daily expected return is at this time at 0.4%. The volatility of related hype on Zymeworks Common is about 1594.25%, with the expected price after the next announcement by competition of 22.40. About 99.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 0.85. Zymeworks Common Stock had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 13 days. Check out Zymeworks Common Basic Forecasting Models to cross-verify your projections.Zymeworks Common Related Hype Analysis
Having access to credible news sources related to Zymeworks Common's direct competition is more important than ever and may enhance your ability to predict Zymeworks Common's future price movements. Getting to know how Zymeworks Common's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Zymeworks Common may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MAZE | Maze Therapeutics Common | 1.21 | 8 per month | 2.56 | 0.17 | 6.61 | (4.37) | 16.60 | |
| ARDX | Ardelyx | 0.44 | 8 per month | 2.70 | 0.14 | 10.57 | (4.91) | 29.66 | |
| SYRE | Spyre Therapeutics | (2.18) | 7 per month | 2.35 | 0.15 | 7.15 | (3.87) | 20.03 | |
| PHVS | Pharvaris BV | (1.45) | 7 per month | 3.20 | 0.07 | 6.58 | (6.01) | 27.81 | |
| NTLA | Intellia Therapeutics | 0.73 | 7 per month | 0.00 | (0.08) | 10.12 | (8.64) | 42.23 | |
| BCRX | BioCryst Pharmaceuticals | (0.21) | 7 per month | 0.00 | (0.05) | 4.49 | (4.55) | 16.75 | |
| IMNM | Immunome | (0.26) | 12 per month | 3.85 | 0.16 | 7.87 | (5.33) | 31.45 | |
| TRVI | Trevi Therapeutics | (0.41) | 9 per month | 3.25 | 0.0005 | 6.73 | (5.94) | 25.67 | |
| WVE | Wave Life Sciences | 0.45 | 8 per month | 4.04 | 0.1 | 8.92 | (6.68) | 164.47 | |
| UPB | Upstream Bio | (1.45) | 9 per month | 3.40 | 0.13 | 7.87 | (5.24) | 24.37 |
Zymeworks Common Additional Predictive Modules
Most predictive techniques to examine Zymeworks price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Zymeworks using various technical indicators. When you analyze Zymeworks charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Zymeworks Common Predictive Indicators
The successful prediction of Zymeworks Common stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Zymeworks Common Stock, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Zymeworks Common based on analysis of Zymeworks Common hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Zymeworks Common's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Zymeworks Common's related companies. | 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 0.39 | 0.24 | 0.22 | Revenue Per Share | 1.1 | 1.01 | 0.91 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Zymeworks Stock analysis
When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |